Core Insights - 111, Inc. is a leading tech-enabled healthcare platform in China, focusing on reshaping the healthcare value chain through digital empowerment [3] - The company will participate in a fireside chat on September 5, 2024, to discuss its Q2 2024 earnings and strategic plans for the second half of the year [1] Company Overview - 111, Inc. provides consumers with improved access to pharmaceutical products and healthcare services via its online retail pharmacy, 1 Pharmacy, and an offline virtual pharmacy network [3] - The company offers online healthcare services through its internet hospital, 1 Clinic, which includes online consultations, electronic prescriptions, and patient management [3] - 111 operates the largest virtual pharmacy network in China, enabling offline pharmacies to enhance customer service through cloud-based solutions [3] - The company also provides an omni-channel drug commercialization platform, offering services like digital marketing, patient education, data analytics, and pricing monitoring to strategic partners [3]

SHANGHAI, July 29, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2024, before the U.S. market opens on Thursday, August 29, 2024.111's management team will host an earnings conference call at 7:30 AM U.S. Ea ...

Core Points - 111, Inc. has appointed Grant Thornton Zhitong Certified Public Accountants LLP as its new independent registered public accounting firm, effective July 19, 2024, replacing Deloitte Touche Tohmatsu Certified Public Accountants LLP [1] - The decision to change the accounting firm was made after a careful evaluation process and has received approval from the board of directors and audit committee of 111, Inc. [1] - Grant Thornton will audit and report on the consolidated financial statements of 111, Inc. for the year ending December 31, 2024, and assess the effectiveness of the company's internal control over financial reporting as of the same date [1]

SHANGHAIJuly 17, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst of Water Tower Research ("WTR") on Thursday, July 18, 2024 at 2:00 p.m. ET.Mr. Junling Liu, Co-Founder, Chairman, and Chief Executive Officer of ...

SHANGHAI, June 11, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, announced that the Company has entered into a strategic direct supply partnership (the "Partnership") with Beijing Scrianen Pharmaceutical Co., Ltd. ("Scrianen"), a comprehensive pharmaceutical enterprise that integrates research and development, p ...

111, Inc. (NASDAQ:YI) Q1 2024 Earnings Conference Call May 23, 2024 7:30 AM ET Company Participants Junling Liu - Co-Founder, Chairman and CEO Luke Chen - CFO, 111's Major Subsidiary Haihui Wang - COO Conference Call Participants Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr. Junling Liu, Co-Founder, Chairman and CEO; Mr. Luke Chen, CFO of 111's Major Subsidiary; and Mr. Haihui Wang, ...

Turned to Quarterly Operational Profitability for the First TimeOperating Expenses as a Percentage of Revenues Decreased 120 Basis Points YoY to 5.8%Achieved Positive Operating Cash FlowSHANGHAI, May 23, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the first q ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . OR ☐ SHELL COMPANY REPORT PURSUANT TO SE ...

SHANGHAI, April 30, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2024, before the U.S. market opens on Thursday, May 23, 2024.111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, May 23, 202 ...

111, Inc. (NASDAQ:YI) Q4 2023 Earnings Conference Call March 21, 2024 7:30 AM ET Company Participants Junling Liu - Co-Founder, Chairman & Chief Executive Officer Luke Chen - Chief Financial Officer of 111's Major Subsidiary Conference Call Participants Xipeng Feng - CIBC Operator Hello, everyone and thank you for joining 111's Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr. Junling Liu, Co-Founder, Chairman and CEO; and Mr. Luke Chen, CFO of ...